An official website of the United States government

This repository is under review for potential modification in compliance with Administration directives.
NIH: National Institute of Diabetes and Digestive and Kidney Diseases
NIDDK Central Repository
Search
Filters

Study Acronym

DPPOS

1 - 30 of 30 Results
  • 1
Page
Show:
Study Search Results Table
Title
PMID
PMCID
Public Release Type
Publication Year
DOI
Study Acronym
Request ID(s)
Public Release Origin
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.19878986PMC3135022Journal200910.1016/S0140-6736(09)61457-4DPPOSContributing Study
A long-term mechanistic computational model of physiological factors driving the onset of type 2 diabetes in an individual.29444133PMC5812629Journal201810.1371/journal.pone.0192472DPPOS, DPP20879Secondary Research
A nomogram-based diabetic sensorimotor polyneuropathy severity prediction using Michigan neuropathy screening instrumentations34715551Journal202110.1016/j.compbiomed.2021.104954DPPOS23125Secondary Research
Assessing heterogeneity in surrogacy using censored dataJournal2024DPPOS, DPP23555Secondary Research
Association of Metformin With the Development of Age-Related Macular Degeneration.36547967PMC9936345Journal202310.1001/jamaophthalmol.2022.5567DPPOS21434Secondary Research
Association of Perfluoroalkyl and Polyfluoroalkyl Substances With AdiposityJournal201810.1001/jamanetworkopen.2018.1493DPP, DPPOS20499Secondary Research
Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease.31296647PMC6702604Journal201910.2337/dc18-2254DPPOS20499, 21291Secondary Research
Can Earlier Biomarker Measurements Explain a Treatment Effect on Diabetes Incidence? A Robust Comparison of Four Surrogate MarkersJournal2023DPP, DPPOS23555Secondary Research
Comparison among criteria to define successful weight-loss maintainers and regainers in the Action for Health in Diabetes (Look AHEAD) and Diabetes Prevention Program trials.29046304PMC5698838Journal201710.3945/ajcn.117.157446DPP, DPPOS20943, 21251Secondary Research
Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.28803840PMC5769867Journal201710.1016/S2213-8587(17)30221-8DPP, DPPOS21387Secondary Research
Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors35339377Journal202210.1016/j.jdiacomp.2022.108180DPP, DCCT/EDIC, DPPOS, CRIC21415Secondary Research
Effects of a Diabetes Prevention Program on Type 2 Diabetes Risk Factors and Quality of Life Among Latino Youths With Prediabetes: A Randomized Clinical Trial.36094502PMC9468887Journal202210.1001/jamanetworkopen.2022.31196DPPOS21434Secondary Research
Evaluating surrogate marker information using censored data.28088843PMC5413393Journal201710.1002/sim.7220DPP, DPPOS20673Secondary Research
First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes.18711387PMC2574826Journal200810.1038/ijo.2008.134DPPOSContributing Study
Influence of a New Diabetes Diagnosis on the Health Behaviors of the Patient’s Partner29987075PMC6037527Journal201810.1370/afm.2259DPPOS21442Secondary Research
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.26377054PMC4623946Journal201510.1016/S2213-8587(15)00291-0DPPOSContributing Study
Per- and polyfluoroalkyl substance plasma concentrations and metabolomic markers of type 2 diabetes in the Diabetes Prevention Program Trial33348273PMC8630734Journal202110.1016/j.ijheh.2020.113680DPPOS20499, 21291, 21434Secondary Research
Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.31150976PMC6570418Journal201910.1016/j.envint.2019.05.027DPPOS20499, 21291Secondary Research
Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.32088543PMC7094005Journal202010.1016/j.envint.2020.105573DPPOS20499, 21291Secondary Research
Per- and polyfluoroalkyl substances and calcifications of the coronary and aortic arteries in adults with prediabetes: Results from the diabetes prevention program outcomes study.33631604PMC8721596Journal202110.1016/j.envint.2021.106446DPPOS20499, 21291Secondary Research
Per- and polyfluoroalkyl substances and kidney function: Follow-up results from the Diabetes Prevention Program trial.33482440PMC7929640Journal202110.1016/j.envint.2020.106375DPPOS20499, 21291Secondary Research
Prioritized Concordance Index for Hierarchical Survival Outcomes30957257PMC6800570Journal201910.1002/sim.8157DPPOS21332Secondary Research
Quantifying the Feasibility of Shortening Clinical Trial Duration Using Surrogate Markers34474500PMC8595715Journal202110.1002/sim.9185DPPOS, DPP22454, 23555Secondary Research
Quantitative trait loci, G×E and G×G for glycemic traits: response to metformin and placebo in the Diabetes Prevention Program (DPP)35260800PMC10102970Journal202310.1038/s10038-022-01027-yDPPOS21434Secondary Research
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.11832527PMC1370926Journal200210.1056/NEJMoa012512DPP, DPPOSContributing Study
Robust Approach to Combining Multiple Markers to Improve Surrogacy35426444PMC10347081Journal202210.1111/biom.13677DPP, DPPOS22454, 23555Secondary Research
Temporal trends of concentrations of per- and polyfluoroalkyl substances among adults with overweight and obesity in the United States: Results from the Diabetes Prevention Program and NHANES.34333293PMC8490287Journal202110.1016/j.envint.2021.106789DPPOS20499, 21291Secondary Research
Use of a Metabolic Syndrome Severity Z Score to Track Risk During Treatment of Prediabetes: An Analysis of the Diabetes Prevention Program30275282PMC6196828Journal201810.2337/dc18-1079DPPOS21779Secondary Research
Using a surrogate marker for early testing of a treatment effectConference Presentation2019DPP, DPPOS23555Secondary Research
Weight Loss, Lifestyle Intervention, and Metformin Affect Longitudinal Relationship of Insulin Secretion and Sensitivity36062951PMC9923796Journal202210.1210/clinem/dgac509DPPOS, DPP21434Secondary Research
  • 1
Page